On May 12, 2025, Trident Texofab Ltd approved the conversion of 4,08,333 warrants into an equal number of equity shares at an issue price of Rs. 70 each, increasing the company's paid-up capital to Rs. 1,39,67,093.
AI Assistant
Trident Texofab Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.